# Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

> **NCT07308769** · PHASE4 · RECRUITING · sponsor: **Pharmanutra S.p.a.** · enrollment: 146 (estimated)

## Conditions studied

- Anemia
- Iron Deficiency Anemia (IDA)

## Interventions

- **DIETARY_SUPPLEMENT:** Sucrosomial® Iron (Sideral® Forte)
- **DRUG:** Ferric Maltol (Feraccru®)

## Key facts

- **NCT ID:** NCT07308769
- **Lead sponsor:** Pharmanutra S.p.a.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-11
- **Primary completion:** 2026-05
- **Final completion:** 2026-10
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07308769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07308769, "Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07308769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*